Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Farmers Insurance
Argus Health
AstraZeneca
Colorcon
Medtronic
US Department of Justice
UBS
Queensland Health

Generated: January 19, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207921

« Back to Dashboard

NDA 207921 describes QVAR REDIHALER, which is a drug marketed by Norton Waterford and is included in one NDA. It is available from three suppliers. There are six patents protecting this drug. Additional details are available on the QVAR REDIHALER profile page.

The generic ingredient in QVAR REDIHALER is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
Summary for 207921
Tradename:QVAR REDIHALER
Applicant:Norton Waterford
Ingredient:beclomethasone dipropionate
Patents:6
Formulation / Manufacturing:see details
Pharmacology for NDA: 207921
Suppliers and Packaging for NDA: 207921
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QVAR REDIHALER beclomethasone dipropionate AEROSOL, METERED;INHALATION 207921 NDA A-S Medication Solutions 50090-3459 50090-3459-0 1 INHALER in 1 CARTON (50090-3459-0) > 1 CANISTER in 1 INHALER > 120 AEROSOL, METERED in 1 CANISTER
QVAR REDIHALER beclomethasone dipropionate AEROSOL, METERED;INHALATION 207921 NDA RPK Pharmaceuticals, Inc. 53002-2436 53002-2436-3 1 INHALER in 1 CARTON (53002-2436-3) > 1 AEROSOL, METERED in 1 INHALER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;INHALATIONStrength0.04MG/INH
Approval Date:Aug 3, 2017TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 207921

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Norton Waterford QVAR REDIHALER beclomethasone dipropionate AEROSOL, METERED;INHALATION 207921-001 Aug 3, 2017 ➤ Try a Free Trial ➤ Try a Free Trial
Norton Waterford QVAR REDIHALER beclomethasone dipropionate AEROSOL, METERED;INHALATION 207921-002 Aug 3, 2017 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Baxter
Cerilliant
AstraZeneca
Fuji
Fish and Richardson
Chinese Patent Office
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.